Adaptimmune Therapeutics Plc ADR (ADAPY)

$0.05 0.00 (-1.82%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 45,989,301
Avg Vol 115,232,406
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 15%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Adaptimmune Therapeutics plc, a commercial-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. It develops TECELRA ((famitresgene autoleucel or afami-cel), a genetically modified autologous T-cell immunotherapy for the treatment of adults with unresectable or metastatic synovial sarcoma; Lete-cel for the treatment synovial sarcoma and myxoid liposarcoma; and ADP-5701, which is in Phase 1 clinical trial for the t...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 12 3543 0000
Address:
60 Jubilee Avenue, Milton Park, Abingdon, United Kingdom
steadyhandswin
steadyhandswin Nov. 4 at 7:48 PM
$ADAPY https://www.yahoo.com/news/articles/why-clinical-trial-offering-young-180052231.html
0 · Reply
PaidPiper
PaidPiper Nov. 4 at 7:31 PM
$ADAPY shorts are loaded and nervous, LT bulls are loaded and less nervous. The only thing that matters now is concrete news and it won't be bad news. Then they cover and we profit. Sunrise. Sunset.
0 · Reply
nicanne
nicanne Nov. 4 at 7:27 PM
$ADAPY For all the positive long holders.... let's try 3 days of radio silence and watch the market ... might make the shorts a bit nervous!!!
1 · Reply
michele3
michele3 Nov. 4 at 6:57 PM
$ADAPY just my opinion.. Why would they voluntarily delist themselves ? Why pay debt ? I don’t know what is brewing but definitely something… and I don’t think stock price matters at this point in time.. just hope we will get a clearer picture soon
1 · Reply
stockCryptoHunter
stockCryptoHunter Nov. 4 at 6:41 PM
$ADAPY the whole fking market collapse at the moment so I am not fking worry at all . Holding and aping while dip
0 · Reply
Dardpro
Dardpro Nov. 4 at 6:16 PM
$ADAPY the new $BYND? 🙏🤑
0 · Reply
US_Bull
US_Bull Nov. 4 at 6:08 PM
$ADAPY Exactly we are still entitled to get MS and regulatory payments from lete-cel development. Uza-cel is gone and that is a partnership between GLPG and USWorldmed. Whether GLPG stays in that PS we are gonna find out given they have shelved their cell therapy pipeline
1 · Reply
Herre62
Herre62 Nov. 4 at 5:52 PM
$ADAPY @US_Bull fyi Following at USWM website ” Future development: USWM plans to bring lete–cel to the U.S. market, with potential regulatory approval anticipated in 2026, and will continue development of uza–cel in collaboration with Galapagos.“ A) above this closed on July 2025 and you can find USWM website too B) Galapagos’s discontinue was on latest May 2025 time line … last time updated by USWM
2 · Reply
MuzunguZanz
MuzunguZanz Nov. 4 at 5:51 PM
$ADAPY I am looking at CERO, yesterday it was trading at .06 and today it is at .18 right now. No reason we should not be at .18, absolutely no reason. Both of OTC, CERO is on the worst pink.
0 · Reply
US_Bull
US_Bull Nov. 4 at 5:46 PM
$ADAPY Conference in Oxford, UK could be a catalyst word of mouth for people to buy after the presentations at least that is what I am hoping. But the real catalyst that will move the SP is when the BLA is filed for lete-cel imo.
0 · Reply
Latest News on ADAPY
No data available.
steadyhandswin
steadyhandswin Nov. 4 at 7:48 PM
$ADAPY https://www.yahoo.com/news/articles/why-clinical-trial-offering-young-180052231.html
0 · Reply
PaidPiper
PaidPiper Nov. 4 at 7:31 PM
$ADAPY shorts are loaded and nervous, LT bulls are loaded and less nervous. The only thing that matters now is concrete news and it won't be bad news. Then they cover and we profit. Sunrise. Sunset.
0 · Reply
nicanne
nicanne Nov. 4 at 7:27 PM
$ADAPY For all the positive long holders.... let's try 3 days of radio silence and watch the market ... might make the shorts a bit nervous!!!
1 · Reply
michele3
michele3 Nov. 4 at 6:57 PM
$ADAPY just my opinion.. Why would they voluntarily delist themselves ? Why pay debt ? I don’t know what is brewing but definitely something… and I don’t think stock price matters at this point in time.. just hope we will get a clearer picture soon
1 · Reply
stockCryptoHunter
stockCryptoHunter Nov. 4 at 6:41 PM
$ADAPY the whole fking market collapse at the moment so I am not fking worry at all . Holding and aping while dip
0 · Reply
Dardpro
Dardpro Nov. 4 at 6:16 PM
$ADAPY the new $BYND? 🙏🤑
0 · Reply
US_Bull
US_Bull Nov. 4 at 6:08 PM
$ADAPY Exactly we are still entitled to get MS and regulatory payments from lete-cel development. Uza-cel is gone and that is a partnership between GLPG and USWorldmed. Whether GLPG stays in that PS we are gonna find out given they have shelved their cell therapy pipeline
1 · Reply
Herre62
Herre62 Nov. 4 at 5:52 PM
$ADAPY @US_Bull fyi Following at USWM website ” Future development: USWM plans to bring lete–cel to the U.S. market, with potential regulatory approval anticipated in 2026, and will continue development of uza–cel in collaboration with Galapagos.“ A) above this closed on July 2025 and you can find USWM website too B) Galapagos’s discontinue was on latest May 2025 time line … last time updated by USWM
2 · Reply
MuzunguZanz
MuzunguZanz Nov. 4 at 5:51 PM
$ADAPY I am looking at CERO, yesterday it was trading at .06 and today it is at .18 right now. No reason we should not be at .18, absolutely no reason. Both of OTC, CERO is on the worst pink.
0 · Reply
US_Bull
US_Bull Nov. 4 at 5:46 PM
$ADAPY Conference in Oxford, UK could be a catalyst word of mouth for people to buy after the presentations at least that is what I am hoping. But the real catalyst that will move the SP is when the BLA is filed for lete-cel imo.
0 · Reply
US_Bull
US_Bull Nov. 4 at 5:41 PM
$ADAPY I have consistently always said don't rely on me solely to find the golden nuggets always do your own DD never trust anyone blindly on ST. I will be here until the end and I will post the board when I sell my position. The value of the company is not down here, the intellectual property, pre-clinical assets, MS and regulatory payments are easily worth multiples of current market cap.
0 · Reply
Damage111
Damage111 Nov. 4 at 5:38 PM
$ADAPY The whole market is red today not worried
0 · Reply
PaidPiper
PaidPiper Nov. 4 at 5:33 PM
$ADAPY also if it makes y'all feel better, @US_Bull and I are NOT in collaboration we just agree that this isn't as black and white as it seems. No one is TRYING to dupe you, MFer doesnt even follow me back🖕🏽 lolz
0 · Reply
PaidPiper
PaidPiper Nov. 4 at 5:14 PM
$ADAPY someone here has a terrible sense of market mechanics.
0 · Reply
US_Bull
US_Bull Nov. 4 at 5:14 PM
$ADAPY GLPG ER has nothing to do with us since they gave up their cell therapy. I see lete-cel BLA submission as the next catalyst (they said EOY) and UK conference in Oxford in few days. I don't believe they are presenting anything at SITC only 1 director is present Kristen.
0 · Reply
PaidPiper
PaidPiper Nov. 4 at 5:11 PM
$ADAPY support comfirmed. Sell a kidney to buy more. This not financial or medical advice.
1 · Reply
Herre62
Herre62 Nov. 4 at 5:10 PM
$ADAPY @TimeForChangeNow i regret to say he could be right .. This one has nothing to do with market … Huge manipulation is in display and Ask is 3 times larger than Bid… Selling big time … I had to say that no one will make money here , we have about toll Nov 13 to have some good news otherwise we all get screwed big time .. News are expecting : a) Adaptimmune conference B) USWM press release C) Galapagos / earnings D) Adapy Earnings with press release otherwise we have to be very patience .. Once again instead of arguing with nice mouth or accepting reality .. Learning is always good . “who said you cannot teach new tricks to old dog. ” Just open to learn others view with Optimism .. we can disagree with respectful matter too..
1 · Reply
PaidPiper
PaidPiper Nov. 4 at 5:04 PM
$ADAPY almost positive we're finding support here at .038
0 · Reply
TRUMP20290
TRUMP20290 Nov. 4 at 4:58 PM
$ADAPY 10.00 to 30.00..🎯🎯🎯🎯🎯🎯🎯🎯🎯🎯🎯🎯🎯PATIENCE
3 · Reply
PaidPiper
PaidPiper Nov. 4 at 4:54 PM
$ADAPY I doubt there’s any coordinated effort like that — more likely just market exhaustion and fear after the merger. ADAPY still has contractual rights and preclinical assets, so it’s not “dead,” but until there’s clarity on the BLA filing and milestone payments, the market’s going to price it cheap. If US WorldMeds pushes Lete-cel forward and the 2026 approval timeline holds, that’s when sentiment flips fast assuming no deal is made before then.
0 · Reply
berat2209
berat2209 Nov. 4 at 4:52 PM
$ADAPY are hopes fading :(
1 · Reply
Rmead78
Rmead78 Nov. 4 at 4:52 PM
$ADAPY added 100K here LFG
0 · Reply